Drugs / Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live
Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00984295 | Jun 2000 → Oct 2001 | chickenpox, measles, mumps infectious disease, rubella | Merck Sharp & Dohme LLC | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles, Mumps, Rubella and Varicella (Oka-Merck) Virus Vaccine Live | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00984295 ↗ |
| Modality | Vaccine | “combination measles, mumps, rubella and varicella vaccine (MMRV)” PMID 16567978 ↗ Apr 2006 |
| Route | Subcutaneous | “subcutaneous injection” NCT00984295 ↗ |